Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates 
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals 
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp 
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions 
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature 
Anthropic Reportedly Taps Wilson Sonsini as It Prepares for a Potential 2026 IPO 
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 
Proxy Advisors Urge Vote Against ANZ’s Executive Pay Report Amid Scandal Fallout 
Visa to Move European Headquarters to London’s Canary Wharf 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
Magnum Audit Flags Governance Issues at Ben & Jerry’s Foundation Ahead of Spin-Off 
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX 
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum 
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift 
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban 
NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Texas on behalf of investors who purchased Nobilis Health Corp. (NYSE:HLTH) securities between April 2, 2015 and October 8, 2015.
Click here to learn about the case: http://docs.wongesq.com/HLTH-Info-Request-Form-951. There is no cost or obligation to you.
The complaint alleges that defendants failed to disclose during the Class Period that the Company’s claimed success rates for its AccuraScope procedure lacked recognition from any university, medical body, or insurance company, that the Company overstated its 2014 revenues by as much as $36 million, and that, as a result of the aforementioned, the Company’s 2014 revenue growth rate was actually 44% as opposed to the 161% represented by the Company.
On October 9, 2015, Seeking Alpha published a report on Nobilis asserting, among other things: accounting red flags, questionable marketing practices and substantial insider sales. Shares have fallen from a closing price of $5.24 per share on October 8, 2015, to a close of just $3.06 per share on October 28, 2015.
If you suffered a loss in Nobilis Health you have until December 21, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/HLTH-Info-Request-Form-951.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
